Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes

Nishant Mante, Vaishali Undale, Avinash Sanap, Ramesh Bhonde, Poonam Suryawanshi

Open source

DOI
10.1016/j.tice.2026.103979
Published
2027-02
Container
Tissue and Cell
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tice.2026.103979,
  title = {Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes},
  author = {Nishant Mante and Vaishali Undale and Avinash Sanap and Ramesh Bhonde and Poonam Suryawanshi},
  year = {2027},
  journal = {Tissue and Cell},
  doi = {10.1016/j.tice.2026.103979},
  url = {https://doi.org/10.1016/j.tice.2026.103979}
}

RIS

TY  - JOUR
TI  - Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes
AU  - Nishant Mante
AU  - Vaishali Undale
AU  - Avinash Sanap
AU  - Ramesh Bhonde
AU  - Poonam Suryawanshi
PY  - 2027
JO  - Tissue and Cell
DO  - 10.1016/j.tice.2026.103979
UR  - https://doi.org/10.1016/j.tice.2026.103979
ER  - 

APA

Mante, N., Undale, V., Sanap, A., Bhonde, R., & Suryawanshi, P. (2027). Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes. Tissue and Cell. https://doi.org/10.1016/j.tice.2026.103979

Source records